Publications by authors named "J Mainz"

Claim this Profile
T
The validated French CFAbd-Score reveals a lower burden of gastrointestinal symptoms in patients on Elexacaftor/Tezacaftor/Ivacaftor.
Isabelle Sermet-Gaudelus, Pauline Sadrieh, Anne Sophie Bonnel, Raphael Enaud, Nathalie Wizla, Jochen Georg Mainz

J Pediatr Gastroenterol Nutr· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immersive Virtual Reality-Assisted Therapy for Distressing Voices in Psychosis: Qualitative Study of Participants' and Therapists' Experiences in the Challenge Trial.
Mads Juul Christensen, Matilde Poulsen Rydborg, Rikke Jørgensen, Cecilie Dueholm Nielsen, Jan Mainz

JMIR Serious Games· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the CFAbd-Score.kid, a Novel gastrointestinal patient reported outcome measure, specific for children with cystic fibrosis.
Pauline Sadrieh, Lilith Bechinger, Franziska Duckstein, Anton Barucha, Lutz Nährlich, Jochen G Mainz

J Cyst Fibros· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel CFAbd-Score.kid reveals a significant decline of abdominal symptoms in children with Cystic fibrosis aged 6 through 11 years on Elexacaftor/Tezacaftor/Ivacaftor - first results.
Jochen G Mainz, Pauline Sadrieh, Lilith Bechinger, Franziska Duckstein, Anton Barucha

J Cyst Fibros· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Antibiotic Therapy on the Upper Respiratory Tract and Gut Mycobiome in Patients with Cystic Fibrosis.
Cristina Zubiria-Barrera, Malena Bos, Robert Neubert, Jenny Fiebig, Michael Lorenz, Jochen G Mainz

J Fungi (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis